explore -WSS

explore

author：leisure time 2025-09-03 03:28:32 - browse：59146

Cambridge: Biogen — Ruby Wallau for STAT

Biogen, the iconic but embattled biotech firm, is shuttering Biogen Digital Health, its roughly 150-person group focused on using new types of data like those from mobile phones and smart watches, and ending a clinical trial being conducted with Apple early, STAT has learned.

Biogen confirmed the organizational change, but said it might lean even more on digital tech startups in the future.

“It’s certainly not an abandonment of digital, it’s more of a realignment of resources and priorities,” said Adam Keeney, Biogen’s executive vice president and head of corporate development. However, he later acknowledged, Biogen Digital Health, a separate entity, “would no longer continue in its current form.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： IVG is promising — but it won’t replace IVF quite yet

entertainment

focus

WSS

Covid vaccine financial winners and losers, from Pfizer to Novavax

The Karikó problem: Lessons for funding basic research

WHO recommends second malaria vaccine

RSV injection headlines need to be accurate for good uptake

Eliminate the waiting period for sterilization covered by Medicaid

Merck drug for rare lung condition set for approval in U.S.

Wikipedia

explore

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The Readout: Lenmeldy, GLP

Heart attack and stroke risk calculators need revising

Study points to new risk in gene therapy death of Terry Horgan

Activists slam private health insurers over coverage restrictions

Lawsuit highlights wrinkle for disputes over surprise medical bills

Jerome Adams on the need for new antivirals for Covid

The Karikó problem: Lessons for funding basic research

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

What will Novo Nordisk's VC do with its influx of cash?

hotspot

Roche subsidiary Foundation Medicine opens new headquarters

Study points to new risk in gene therapy death of Terry Horgan

New oral drug delivery patch is modeled after octopus tentacles

Eliminate the waiting period for sterilization covered by Medicaid

Some top drug companies are starting to take action on climate

Readout Newsletter: Merck, Vertex, and Viking updates

entertainment

focus

hotspot

focus